TCGX
TCGXCIK 0002137965
Every 8-K is open in full. Other 10-Ks and 10-Qs show a 3-bullet preview. A free account reads 3 more full reports a month. Generating a report requires a verified account.
Sign up freeWant to see a complete report first? Today's free report (NRIX 10-Q) is open in full — no account needed.
Summary not yet generated.
Summary not yet generated.
Partner
Trade TCGX commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Summary not yet generated.
TCGX Acquisition Corp. prices $75M SPAC IPO at $10 per share, with $20M forward purchase commitment
5 material changes detected. Sign up free to read the summary.
Summary not yet generated.
TCGX, a blank check company, files for $75M IPO at $10.00 per share to fund a healthcare acquisition
6 material changes detected. Sign up free to read the summary.
Latest financial statements
From 10-Q filed Sep 10, 2026 (period ending Jun 30, 2026). As printed on the EDGAR/iXBRL face — not generated by the model.
Condensed Statement of Operations (Unaudited)
| Description | PERIOD FROM MAY 26, 2026 (INCEPTION) THROUGH June 30, 2026 |
|---|---|
| Formation, general and administrative costs | 67,614 |
| Net loss | (67,614) |
| Basic and diluted weighted average Class B ordinary shares outstanding(1)(2) | 1,875,000 |
| Basic and diluted net loss per Class B ordinary share | (0.04) |
Condensed Balance Sheet (Unaudited)
| Description | June 30, 2026 |
|---|---|
| Prepaid expenses | 6,793 |
| Total Current Assets | 6,793 |
| Deferred offering costs | 246,383 |
| Total Assets | 253,176 |
| Liabilities and Shareholders’ Deficit | |
| Current Liabilities | |
| Accrued expenses | 6,012 |
| Accrued offering costs | 246,383 |
| Promissory note related party | 43,395 |
| Total Current Liabilities | 295,790 |
| Commitments and Contingencies (Note 6) | |
| Shareholders’ Deficit | |
| Preference shares, $0.0001 par value; 1,000,000 shares authorized; none issued or outstanding | — |
| Class A ordinary shares, $0.0001 par value; 200,000,000 shares authorized; none issued or outstanding | — |
| Class B ordinary shares, $0.0001 par value; 20,000,000 shares authorized; 2,156,250 shares issued and outstanding(1)(2) | 216 |
| Additional paid-in capital | 24,784 |
| Accumulated deficit | (67,614) |
| Total Shareholders’ Deficit | (42,614) |
| Total Liabilities and Shareholders’ Deficit | 253,176 |
Condensed Statement of Cash Flows (Unaudited)
| Description | PERIOD FROM MAY 26, 2026 (INCEPTION) THROUGH June 30, 2026 |
|---|---|
| Net loss | (67,614) |
| Adjustments to reconcile net loss to net cash used in operating activities: | |
| Formation, general and administrative costs paid by Sponsor in exchange for issuance of founder shares | 18,207 |
| Formation, general and administrative costs paid through promissory note related party | 43,395 |
| Changes in operating assets and liabilities: | |
| Accrued expenses | 6,012 |
| Net cash used in operating activities | — |
| Net change in cash | — |
| Cash, beginning of the period | — |
| Cash, end of the period | — |
| Non-cash investing and financing activities: | |
| Deferred offering costs included in accrued offering costs | 246,383 |
| Prepaid expenses contributed by Sponsor in exchange for issuance of Class B ordinary shares | 6,793 |
Amounts as printed on the EDGAR/iXBRL face. Labels, columns, and figures are the filing face, not a GAAP stencil. Interactive statements & notes on EDGAR ↗